The United States Patent and Trademark Office (USPTO) has granted a new U.S. patent for Palisade Bio’s (NASDAQ:PALI) lead investigational drug product, LB1148, for use in treating adhesions and postoperative ileus...
Cognetivity Neurosciences (CSE:CGN; OTCQB:CGNSF; FWB:1UB) entered a collaborative partnership with Ketamine One Capital to study and develop assessments for depression and post-traumatic stress disorder (PTSD). In the...
Altamira Therapeutics (NASDAQ:CYTO) randomized the first patient in its NASAR trial for the clinical evaluation of Bentrio (AM-301) in seasonal allergic rhinitis (SAR). Bentrio, a drug-free nasal spray intended for...
BeyondSpring Pharmaceuticals (NASDAQ:BYSI) received a complete response letter (CRL) from the FDA for its NDA seeking approval of plinabulin in combination with granulocyte colony-stimulating factor (G-CSF) for the...
Palisade Bio (NASDAQ:PALI) was advised by the European Patent Office that it will receive a patent for its lead investigational drug product, LB1148. The patent will publish on Dec. 22, 2021, and provide protection...
Tetra Bio-Pharma (TSX:TBP; OTCQB:TBPMF; FRA:JAM1) reported positive initial clinical data from its ongoing Phase 2 REBORN 1 and PLENITUDE trials of QIXLEEF for cancer pain. QIXLEEF is a botanical inhaled investigational...
POINT Biopharma Global (NASDAQ:PNT) entered into a technology license agreement with the Belgian Nuclear Research Center (SCK CEN) for Lu-177 purification technology to accelerate POINT’s in-house no-carrier-added...
111, Inc. (NASDAQ:YI), a leading tech-enabled healthcare platform in China, reported that third quarter net revenue rose 41.6% to RMB3.35 billion, or $519.3-milion (U.S.). In a statement, Junling Liu, co-founder...
Oravax Medical, a unit of Oramed Pharmaceuticals (NASDAQ, TASE:ORMP), and Genomma Lab Internacional (BMV:LABB) formed of a 50/50 joint venture to develop and commercialize Oravax’s oral COVID-19 vaccine candidate...
In-network psychiatric care provider, Talkiatry, appointed Vanessa Cao as SVP of operations as the company prepares for a national rollout. With more than 10 years of experience in operations, Ms. Cao joins Talkiatry...